EMLA versus nitrous oxide for venous cannulation in children

Area of Science:

• Pediatric Anesthesiology
• Pain Management
• Medical Device Technology

Background:

• Venous cannulation in children can cause significant pain and distress.
• Effective pain management strategies are crucial for pediatric procedures.
• Comparing topical anesthetics with inhaled agents offers insights into procedural comfort.

Purpose of the Study:

• To compare the efficacy of EMLA cream versus nitrous oxide (N2O) for pain relief during venous cannulation in children.
• To evaluate patient-reported pain scores and procedural ease.
• To assess the incidence of side effects associated with each intervention.

Main Methods:

• A prospective, double-blinded, randomized study involving 40 children aged 6-11 years.
• Participants received either EMLA cream or a placebo cream, combined with inhaled air/oxygen or 70% N2O/oxygen, respectively.
• Pain was assessed using Visual Analog Scale (VAS) and Objective Pain Scale (OPS); procedural ease and physiological variables were also monitored.

Main Results:

• No statistically significant differences were found in VAS scores, OPS scores, or ease of cannulation between the EMLA and N2O groups.
• Both EMLA and N2O provided adequate pain relief, indicated by low pain scores.
• Minor side effects were significantly more common in the N2O group (11/20) compared to the EMLA group (7/20).

Conclusions:

• EMLA cream and nitrous oxide are equally effective in providing pain relief during venous cannulation in children.
• EMLA cream may be associated with fewer minor side effects compared to nitrous oxide.
• Both interventions offer adequate pain management for this common pediatric procedure.